Seminars in Hematology
Volume 37, Issue 3 , Pages 275-289 , July 2000

Management of idiopathic thrombocytopenic purpura in pregnancy

  • Karamjit K Gill
    • ,
  • John G Kelton

      Affiliations

    • Corresponding Author InformationAddress reprint requests to John G. Kelton, MD, Room 3W10, McMaster University Medical Centre, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.

References 

  1. Adams DM, Bussel JB, Druzin ML. Accurate intrapartum estimation of fetal platelet count by fetal scalp sample smear. Am J Perinatol. 1994;11:42–50
  2. Ahmed Y, Van Iddekinge B, Paul C, et al.  Retrospective analysis of platelet numbers and volumes in normal pregnancy. Thromb Haemost. 1997;77:806–808
  3. Ajzenberg N, Dreyfus M, Kaplan C, et al.  Pregnancyassociated thrombocytopenia revisited: Assessment and follow-up of 50 cases. Blood. 1998;92:4573–4580
  4. Al-Jama FE, Raham J, Al-Suleiman SA, et al.  Outcome of pregnancy in women with idiopathic thrombocytopenic purpura. Aust NZ J Obstet Gynaecol. 1998;38:410–413
  5. Al-Mofada SM, Osman MEE, Kides E, et al.  Risk of thrombocytopenia in the infants of mothers with idiopathic thrombocytopenia. Am J Perinatal. 1994;11:423–426
  6. Burrows RF, Kelton JG. Alloimmune neonatal thrombocytopenia associated with incidental maternal thrombocytopenia. Am J Hematol. 1990;35:43–44
  7. Burrows RF, Hunter DJS, Andrew M, et al.  A prospective study investigating the mechanism of thrombocytopenia in preeclampsia. Obstet Gynecol. 1987;70:334–338
  8. Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med. 1993;329:1463–1466
  9. Burrows RF, Kelton JG. Incidentally detected thrombocytopenia in healthy mothers and their infants. N Engl J Med. 1988;319:142–145
  10. Burrows RF, Kelton JG. Platelets and pregnancy. In:  Lee RV,  Barron WM,  Cotton DB, et al. editor. Current Obstetric Medicine. vol 2:St Louis, MO: Mosby; 1993;p. 83–106
  11. Burrows RF, Kelton JG. Thrombocytopenia at delivery: A prospective survey of 6715 deliveries. Am J Obstet Gynecol. 1990;162:732–734
  12. Burrows RF, Kelton JG. Low fetal risks in pregnancies associated with idiopathic thrombocytopenic purpura. Am J Obstet Gynecol. 1990;163:1147–1150
  13. Burrows RF, Kelton JG. Pregnancy in patients with idiopathic thrombocytopenic purpura: assessing the risks for the infant at delivery. Obstet Gynecol Surv. 1993;48:781–788
  14. Bussel JB, Christiaens G. Birth platelet counts in sequential newborns of mothers with ITP: Do the platelet counts change with subsequent babies?. Blood. 1993;82(suppl 1):202a; abstr
  15. Bussel JB, Zabusky MR, Berkowitz RL, et al.  Fetal alloimmune thrombocytopenia. N Engl J Med. 1997;337:22–26
  16. Byrne JD, Incerpi MH, Goodwin TM. Idiopathic thrombocytopenic purpura in pregnancy treated with pulsed highdose oral dexamethsaone. Am J Obstet Gynecol. 1999;177:468–469
  17. Chandran R, Serra-Serra V, Redman CWG. Spontaneous resolution of pre-eclampsia—related thrombocytopenia. Br J Obstet Gynecol. 1992;99:887–890
  18. Christiaens GCML, Nieuwenhuis HK, Bussel JB, et al.  Comparison of platelet counts in first and second newborns of mothers with immune thrombocytopenic purpura. Obstet Gynecol. 1997;90:546–552
  19. Christiaens GCML, Nieuwenhuis HK, Von Dem AEGK, et al.  Idiopathic thrombocytopenic purpura in pregnancy: A randomized trial on the effect of antenatal low dose corticosteroids on neonatal pktelet count. Br J Obstet Gynaecol. 1990;97:893–898
  20. Cincotta R, Ross A. A review of eclampsia in Melbourne: 1978–1992. Aust NZ J Obstet Gynecol. 1996;36:264–267
  21. Cines DB, Dusak B, Tomaski A, et al.  Immune thrombocytopenic purpura and pregnancy. N Engl J Med. 1982;306:826–831
  22. Cook RL, Miller RC, Katz VL, et al.  Immune thrombocytopenic purpura in pregnancy: A reappraisal of management. Obstet Gynecol. 1991;78:578–583
  23. Fay RA, Hughes AO, Farron NT. Platelets in pregnancy: Hyperdestruction in pregnancy. Obstet Gynecol. 1983;61:238–240
  24. Gandemer V, Kaplan C, Quelvennec E, et al.  Pregnancy-associated autoimmune neonatal thrombocytopenia: Role of maternal HLA genotype. Br J Haematol. 1999;104:878–885
  25. Garmel SH, Craigo SD, Morin LM. The role of percutaneous umbilical blood sampling in the management of immune thrombocytopenic purpura. Prenat Diagn. 1995;15:439–445
  26. George JN, Woolf SH, Raskob GE, et al.  Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3–40
  27. Giacoia GP, Azubuike K. Autoimmune diseases in pregnancy: Their effect on the fetus and newborn. Obstet Gynecol Surv. 1991;46:723–732
  28. Gottlieb P, Azelsson O, Bakos O, et al.  Splenectomy during pregnancy: An option in the treatment of autoimmune thrombocytopenic purpura. Br J Obstet Gynaecol. 1999;106:373–375
  29. Hart D, Dunetz C. An epidemic of maternal thrombocytopenia associated with elevated antiplatelet antibodies, platelet count and antiplatelet antibodies in 116 consecutive pregnancies: Relationship to neonatal platelet count. Am J Obstet Gynecol. 1986;154:878–883
  30. He R, Reid DM, Jones CE. Spectrum of Ig classes, specificites, and titres of serum antiglycoproteins in chronic idiopathic thrombcytopenic purpura. Blood. 1994;83:1024–1032
  31. Hohlfeld P, Forestier F, Kaplan C, et al.  Fetal thrombocytopenia: A retrospective survey of 5,194 fetal blood samplings. Blood. 1994;84:1851–1856
  32. Johnson JR, Samuels P. Review of autoimmune thrombocytopenia: Pathogenesis, diagnosis, and management in pregnancy. Clin Obstet Gynecol. 1999;42:317–326
  33. Kaplan C, Daffos F, Forestier F, et al.  Fetal platelet counts in thrombocytopenic pregnancy. Lancet. 1990;336:979–982
  34. Kaplan C, Forestier F, Dreyfus M, et al.  Maternal thrombocytopenia during pregnancy: Diagnosis and etiology. In: Semin Thromb Hemost. 21:1995;p. 85–94
  35. Karpatkin M, Porges RF, Karpatkin S. Platelet counts in infants of women with autoimmune thrombocytopenia. N Engl J Med. 1981;305:936–938
  36. Katz VL, Thorp JM, Rozas L, Katz VL, Thorp JM, Rozas L, et al.  The natural history of thrombocytopenia associated with preeclampsia. Am J Obstet Gynecol. 1990;163:1142–1143
  37. Kelton JG. The serological investigation of patients with autoimmune thrombocytopenia. Thromb Hemost. 1995;74:228–233
  38. Kelton JG. Management of the pregnant patient with idiopathic thrombocytopenic purpura. Ann Intern Med. 1983;99:796–800
  39. Laros RK, Kagan R. Route of delivery for patients with immune thrombocytopenic purpura. Am J Obstet Gynecol. 1984;148:901–908
  40. Letsky EA, Greaves M. Guidelines on the investigation and management of thrombocytopenia in pregnancy and neonatal alloimmune thrombocytopenia. Maternal and Neonatal Haemostasis Working Party of the Haemostasis and Thrombosis Task Force of the British Society for Haematology. Br J Haematol. 1996;95:21–26
  41. Magann EF, Perry KG, Meydrech EF, et al.  Postpartum corticosteroids: Accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol. 1994;171:1154–1158
  42. Martin JN, Files JC, Blake PG, et al.  Plasma exchange for preeclampsia. I. Postpartum use for persistendy severe preeclampsia-eclampsia with HELLP syndrome. Am J Obstet Gynecol. 1990;162:126–137
  43. Martin JN, Blake PG, Lowry SL, et al.  Pregnancy complicated by preeclampsia-eclampsia with the syndrome of hemolysis, elevated liver enzymes, and low platelet count: How rapid is postpartum recovery?. Obstet Gynecol. 1990;76:737–741
  44. Mazzucconi MG, Petrelli V, Gandolfo GM, et al.  Autoimmune thrombocytopenic purpura in pregnancy: Maternal risk factors predictive of neonatal thrombocytopenia. Autoimmunity. 1993;16:209–214
  45. McCrae KR, Samuels P, Schreiber AD. Pregnancy-associated thrombocytopenia: pathogenesis and management. Blood. 1992;80:2697–2714
  46. Moise KJ, Cotton DB. Discordant fetal platelet counts in a twin gestation complicated by idiopathic thrombocytopenic purpura. Am J Obstet Gynecol. 1987;156:1141–1142
  47. Moise KJ, Carpenter RJ, Cotton DB, et al.  Percutaneous umbilical cord blood sampling in the evaluation of fetal platelet counts in pregnant patients with autoimmune thrombocytopenia purpura. Obstet Gynecol. 1988;72:346–350
  48. Moutet A, Fromont P, Farcet JP, et al.  Pregnancy in women with immune thrombocytopenic purpura. Arch Intern Med. 1990;150:2141–2145
  49. Neiger R, Contag SA, Coustan DR. Preeclampsia effect on platelet count. Am J Perinatol. 1992;9:378–380
  50. Pachi A, Carapella E, Mazzucconi MG, et al.  Autoimmune thrombocytopenic purpura: Maternal and fetal disease. Early Hum Dev. 1992;29:143–147
  51. Payne SD, Resnik R, Moore TR, et al.  Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial hemorrhage in pregnancies complicated by autoimmune thrombocytopenia. Am J Obstet Gynecol. 1997;177:149–155
  52. Peleg D, Hunter SK. Perinatal management of women with mmune thrombocytopenic purpura: Survey of United States perinatologists. Am J Obstet Gynecol. 1999;180:645–649
  53. Rasmus KT, Rottman RL, Kotelko DM, et al.  Unrecognized thrombocytopenia and regional anesthesia in parturients: A retrospective review. Obstet Gynecol. 1989;73:943
  54. Rolbin SH, Abbott D, Musclow E, et al.  Epidural analgesia in pregnant patients with low platelet counts. Obstet Gynecol. 1988;71:918–920
  55. Reyes H, Sandoval L, Wainstein A, et al.  Acute fatty liver of pregnancy: A clinical study of 12 episodes in 11 patients. Gut. 1994;35:101–106
  56. Sainio S, Joutsi L, Jarvenpaa AL. Idiopathic thrombocytopenic purpura in pregnancy. Acta Obstet Gynecol Scand. 1998;77:272–277
  57. Samuels P, Bussel JB, Braitman LE, et al.  Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura. N Engl J Med. 1990;323:229–235
  58. Saphier CJ, Repke JT. Hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: A review of diagnosis and management. In: Semin Perinatol. 22:1998;p. 118–133
  59. Scioscia AL, Grannum AT, Copel JA, et al.  The use of percutaneous umbilical cord sampling in immune thrombocytopenic purpura. Am J Obstet Gynecol. 1988;159:1066–1068
  60. Sharon R, Tatarsky I. Low fetal morbidity in pregnancy associated with acute and chronic idiopathic thrombocytopenic purpura. Obstet Gynecol. 1997;90:546–552
  61. Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): Much ado about nothing. Am J Obstet Gynecol. 1990;162:311–316
  62. Sibai BM, Mercer BM, Schiff E, et al.  Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: A randomized controlled trial. Am J Obstet Gynecol. 1994;171:818–822
  63. Sibai BM. Prevention of preeclampsia: A big disappointment. Am J Obstet Gynecol. 1998;179:1275
  64. Sibai BM, Taslimi MM, El-Nazer A, et al.  Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsiaeclampsia. Am J Obstet Gynecol. 1986;155:501–509
  65. Sibai BM. Prevention of preeclampsia: A big disappointment. Am J Obstet Gynecol. 1998;179:1275–1278
  66. Silver RM, Branch DW, Scott JR. Maternal thrombocytopenia in pregnancy: Time for a reassessment. Am J Obstet Gynecol. 1995;173:479–482
  67. Sullivan CA, Magann EF, Perry KG, et al.  The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations. Am J Obstet Gynecol. 1994;171:940–943
  68. Valat AS, Caulier MT, Devos P, et al.  Relationships between severe neonatal thrombocytopenia and maternal characteristics in pregnancies associated with autoimmune thrombocytopenia. Br J Haematol. 1998;103:397–401
  69. Verdy E, Bessous V, Dreyfus M. Thromb Haemost. 1997;77:806–807
  70. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: A severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982;142:159–167
  71. Witlin AG. Counseling for women with preeclampsia or eclampsia. In: Semin Perinatol. 23:1999;p. 91–98
  72. Yamada H, Fujimoto S. Perinatal management of idiopathic thrombocytopenic purpura in pregnancy: Risk factors for passive immune thrombocytopenia. Ann Hematol. 1994;68:39–42
  73. Yamada H, Kato EH, Kishida T, et al.  Risk factors for neonatal thrombocytopenia in pregnancy complicated by idiopathic thrombocytopenic purpura. Ann Hematol. 1998;76:211–214

☆ Supported in pan by a grant from the Medical Research Council of Canada.

PII: S0037-1963(00)90106-9

Seminars in Hematology
Volume 37, Issue 3 , Pages 275-289 , July 2000

Article Tools